Belfrics completes Blockchain-based M1 demo for India

Belfrics completes Blockchain-based M1 demo for India

AVENTURA, Fla., Sept. 02, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) announced today that Mr. Vazeem Jadeer – Director, Mr. Satish Shekar – Principal Consultant and Sanchi Singh – Category and Relationship Manager at BelfricsBT Private Limited, met with officials from India’s National Health Authority (NHA) on 24 August 2022 to complete the first blockchain-based M1 (Milestone 1) demo and discuss how Belfrics can make ABDM blockchain-compatible for various modules within the ABDM ecosystem such as insurance and healthcare personnel membership modules. India’s National Health Authority (NHA) is the apex body responsible for implementing India’s flagship public health insurance and insurance program called the Ayushman Bharat Digital Mission (ABDM). The National Health Authority, Government of India has been entrusted with the role of designing strategy, building technological infrastructure and implementing the “National Digital Health Mission”, which will create a national digital health ecosystem.

All the companies that have completed the M1 license have gone live and are bringing citizens on board to generate health IDs. Belfrics is currently working to deliver a permanent solution using its KYC Belrium blockchain to eliminate some of the bugs identified during implementation. Within the next 30 days, Belfrics intends to obtain an M1 license and also complete M2 and M3 (Milestones 2 and 3) within the next 3 months. The authorities also asked Belfrics to submit a white paper on how the “Belrium Blockchain” can be used by ABDM where blockchain will provide a strategic advantage. Belfrics was also asked to submit a proposal to profile the state government facilities and practitioners on the blockchain. This will help the ecosystem of ABDM as healthcare is a state subject in India.

Belfric’s CEO and founder, Praveen Kumar, said, “BelYo is our healthcare dApp that can be used for any healthcare department that involves identity or document management. Patient record management, patient registration, patient ID, healthcare provider certificate, healthcare facility certificate and vaccination records can all be issued using BelYo platform BelYo is a product originally developed by Takshay Labs Pvt Ltd (formerly known as Sync Labs Pvt Ltd) and BelfricsBT Sdn Bhd for a COVID19 challenge initiated by International Institute of Information Technology, Bangalore (IIIT-B) and supported by Mphasis F1 Foundation grant. After covid, all citizens were required to have a blockchain wallet to receive and share the blockchain based covid certificate, which is why officials asked the founders of BelYo to participate in the National Health Authorities ABDM project.”

See also  Cardano TVL up 565,000%, Snoop Dogg praises ADA blockchain

Mr. Kumar added, “This is a huge opportunity for Belfrics to partner with ABDM using our Belrium blockchain at the architecture level. Our goal is to create an ABDM + Blockchain solution for state governments, along with a blockchain-based PHR ( personal health record) where sharing data outside of India through the ABDM ecosystem will be at our core.Belfrics is the only blockchain company among 57 other vendors and the NHA authorities talked about how they could use Belrium for the ABDM architecture, state government implementations, and a few core modules Belfrics intends to fulfill 20% of the ABDM market (200 million) in the next 5 years, which is the population of India.

Satish Shekar, CEO & Founder, Takshay Labs Pvt Ltd, said: Since the launch of “BelYo”, I have always been optimistic about the Belrium Blockchain and the ecosystem of dApp envisioned by Mr. Kumar. In the process, I also became a member of Belfrics as a lead consultant, and I currently work on BelYo and other dApps for Belfrics. Before getting M1 license, I will transfer my share of “BelYo” to Belfrics.

According to our conversation with the authorities of ABDM, Belfrics learned that since its inception, BelYo is the sole blockchain partner of the Ayushman Bharat Digital Mission (ABDM) and as they noted, has β€œthe potential to bring about a revolutionary change in India’s healthcare.” The flagship digital initiative involves the creation of not only a unique health ID for each citizen, but also a digital healthcare personnel and facility registry with blockchain initiatives, making it safer, more efficient and the most effective blockchain solution for healthcare. .

“At a time when many blockchain providers are struggling and downsizing, Belfrics continues to strengthen its relationship with the Indian government,” said Life Clips CEO Robert Grinberg. “The healthcare sector is moving towards software development, which includes acceleration of Blockchain technology to protect healthcare data. Globally, the Blockchain in Healthcare market is expected to grow at a compound annual growth rate (CAGR) of 61.3% to reach USD 1.19 billion by 2028. As a result of the growing acceptance of blockchain as a service and the openness and immutability of the distributed ledger technology, we believe Belfrics’ BelYo presents tremendous opportunities for our company.” Mr. Grinberg continued, “We look forward to updating shareholders on additional opportunities as well as several important announcements in the coming months.”

See also  Chinese Blockchain Company Develops Payment System for Stablecoins and CBDC

About us

Life Clips is the parent company of Belfrics Global and Cognitive Apps Software Solutions Inc. Belfrics Global is a Malaysian based blockchain provider and cryptocurrency exchange and platform licensed and regulated by the Labuan Financial Services Authority (LFSA), Malaysia. With 10 operational offices in 8 countries, Belfrics’ multi-functional trading platform offers digital assets, cryptocurrencies and crypto derivative contracts to its clients. Belfric’s blockchain has been recognized by Gartner as a top 10 real-world blockchain and has received a patent for its Belrium KYC Verification System (BKVS) by the Nigerian Patent Authority. Cognitive Apps is disrupting mental health with its voice-based, AI-powered mental health analytics platform that empowers businesses to measure, understand and improve the mental well-being of their employees, patients and customers. Aiki delivers CBT and IPT therapies using a chatbot that includes the voice analytics solution that takes in other health data from Apple and Google HealthKit to make a more accurate analysis of one’s mental health. Aiki was developed to capitalize on the trend towards artificial intelligence platforms used by individuals and businesses to raise awareness of employee mental health. Cognitive apps are developed by a team of licensed psychotherapists who use vocal biomarkers to screen for early signs of mental health conditions, such as stress and depression. Aiki is available on Apple’s App Store.

For more information about Life Clip visit www.lifeclips.com
For more information on Belfric’s Global visit www.belfricsgroup.com
For more information about Cognitive Apps Software Solutions, visit

Disclaimer for forward-looking statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “assumes,” ” projects”, “predicts”, “estimates”, “measures”, “believes”, “hopes”, “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified, and accordingly actual results may differ materially from those expressed or implied by such forward-looking statements: (i) initiation, timing, progress and results of the Company’s research, production and other development efforts; (ii) the Company’s ability to advance its products to complete development and commercialization; (iii) the production, development, commercialization and market acceptance of the Company’s products; (iv) lack of sufficient funding to fund product development and business operations; (v) competing companies and technologies within the Company’s industry and the introduction of competing products; (vi) the Company’s ability to establish and maintain corporate partnerships; (vii) loss of key management personnel; (viii) the extent of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to conduct its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting government actions and its regulations. All forward-looking statements included in this press release speak only as of the date of this press release. The Company undertakes no obligation to update any written or oral forward-looking statement except as required by law.

See also  Collections from China's famous caves are moved to the Blockchain database

For media and investor relations, please contact:

David L. Kugelman
(866) 692-6847 Toll Free – US and Canada
(404) 281-8556 Mobile and WhatsApp
[email protected]
Skype: kugsusa

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *